menu search

Respirerx pharmaceuticals notes publication of paper on newest gabakine analog which protects against seizures and lethality

RespireRx Pharmaceuticals (OTCQB:RSPI) Inc has noted the publication of a paper detailing the company's newest ...

March 17, 2022, 9:49 am

Soligenix's covid-19 vaccine candidate as booster neutralizes delta, omicron variants

Soligenix Inc (NASDAQ: SNGX) announced the results of a booster vaccination study using CiVax (heat-stable COVID-19 subunit vaccine program) in non...

March 17, 2022, 9:44 am

Nls pharma shares fall after mazindol er interim data shows 39% improvement on sleepiness scale

NLS Pharmaceutics Ltd (NASDAQ: NLSP) has announced interim topline data from its Phase 2a trial of its lead product ...

March 16, 2022, 2:06 pm

Sonnet shares surge as fda clears its first human trial for solid tumor candidate

The FDA has signed off Sonnet BioTherapeutics Holdings Inc's (NASDAQ: SONN) Investigational New Drug (IND) application for SON-1010, a proprietary ...

March 16, 2022, 9:35 am

Aim immunotech wins ind clearance from fda to proceed with phase 2 study of ampligen for treating locally advanced pancreatic cancer

AIM ImmunoTech Inc (NYSE:AIM) revealed that it has received a notification from the US Food and Drug Administration (FDA) stating that the clinical ho...

March 16, 2022, 9:15 am

Moderna says japanese government has ordered additional 70 million doses of its covid booster vaccine

Moderna Inc. MRNA, -1.30% said Wednesday the Japanese government has ordered an additional 70 million doses of its COVID-19 booster vaccine or an upda...

March 16, 2022, 8:12 am

Applied therapeutics to present at the 2022 annual clinical genetics meeting of the american college of molecular genetics and genomics

NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeli...

March 16, 2022, 7:30 am

Cincor pharma to report fourth quarter and full year 2021 financial results and host conference call on march 22, 2022

BOSTON, March 15, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC), a clinical-stage biopharmaceutical company focused on developing its le...

March 15, 2022, 9:41 am

Enveric biosciences touts the publication of four patent applications for psychedelic-inspired drug candidates

Enveric Biosciences (NASDAQ:ENVB) Inc announced that the company's first four Patent Cooperation Treaty (PCT) applications for the tryptamine family o...

March 15, 2022, 8:57 am

Sanofi's (sny) breast cancer candidate misses goal in study

Sanofi's (SNY) phase II AMEERA-3 study, investigating amcenestrant in ER+/HER2- advanced/metastatic breast cancer, fails to meet the primary endpoint....

March 14, 2022, 1:32 pm

3 bear trades pounce on now

The charts point to lower prices for these struggling stocks. That makes them prime candidates for bear...

March 14, 2022, 11:38 am

5 short squeeze candidates to watch: indonesia energy tops the list, two other oil related stocks join leaderboard

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...

March 14, 2022, 10:05 am

This short-squeeze candidate could actually pan out in the long run

This industry leader can rebound....

March 14, 2022, 9:23 am

Why sanofi shares are trading lower today

Sanofi SA (NASDAQ: SNY) stock slid after its drug candidate, amcenestrant, to fight a common type of b...

March 14, 2022, 8:29 am

Sanofi shares drop on trial setback for breast cancer pill

Shares in Sanofi slumped 5.3% after an oral drug candidate to fight a common type of breast cancer that...

March 14, 2022, 5:20 am

Moderna (mrna) starts omicron-specific bivalent booster study

Moderna (MRNA) administers the first dose in the phase II study of its Omicron-specific bivalent booster candi...

March 11, 2022, 3:48 pm

Mirati (mrtx) focuses on seeking nod for kras drug adagrasib

Mirati's (MRTX) regulatory filing to the FDA for adagrasib in second-line NSCLC gets a longer-than-expected review period. MRTX is progressing well wi...

March 11, 2022, 1:33 pm

Allogene's (allo) car t therapy gets fast track designation

The FDA grants a Fast Track designation to Allogene's (ALLO) early-stage CAR T therapy candidate, ALLO-...

March 11, 2022, 12:48 pm

Generali struggle intensifies as investor plots own ceo candidate

Generali's second-biggest investor, construction tycoon Francesco Gaetano Caltagirone, plans to put forward his own ...

March 11, 2022, 9:51 am

This car parts retailer is a strong candidate for dividend investors

Advance Auto Parts, Inc. (NYSE:AAP) stock has gone by way of the broader market, shedding 14.6% this year so far....

March 11, 2022, 9:43 am


Search within

Pages Search Results: